How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

19,417 results for

Congenital Heart Disease

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Arrhythmias in Congenital Heart Disease: A Position Paper of EHRA, AEPC, and ESC Working Group on Grown-up Congenital Heart Disease

Arrhythmias in Congenital Heart Disease: A Position Paper of EHRA, AEPC, and ESC Working Group on Grown-up Congenital Heart Disease Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE Antonio Herna ´ndez-Madrid 1 * † , Thomas Paul 2 (...) Department of Heart Disease, Haukeland University Hospital, Bergen, Norway; 8 Pediatric and Adult Congenital Heart Centre-University Hospital, IRCCS Policlinico San Donato, Milan, Italy; 9 Arrhythmia Unit, Department of Pediatric and Adult Congenital Heart Disease, Clinique Pasteur, Toulouse, France; 10 Department of Electrophysiology, University Leipzig Heart Center, Leipzig, Germany; 11 University Hospital Muenster, Muenster, Germany; 12 Royal Brompton and Hare?eld Hospital, London, UK; 13 Congenital

2017 Heart Rhythm Society

3. Congenital heart disease

Congenital heart disease Congenital heart disease - Medical information | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Congenital heart disease Last reviewed: February 2019 Last updated: March 2018 Summary Congenital heart disease (CHD) is the most common birth defect, although still relatively rare. Screening for congenital heart disease includes ultrasonography in the second trimester of pregnancy and postnatal clinical examination; however (...) , detection rates are low. Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed. 1999 Jan;80(1):F49-53. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720871/ http://www.ncbi.nlm.nih.gov/pubmed/10325813?tool=bestpractice.com Kardasevic M, Kardasevic A. The importance of heart murmur in the neonatal period and justification of echocardiographic review. Med Arch. 2014 Aug;68(4):282-4. https

2018 BMJ Best Practice

4. Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association

Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February (...) 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 Free Access article Share on Jump to Free Access article Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association , RN, MN, FAHA, Chair , MD, FRCP, Co-Chair , MD , MD , MD , MD, DPhil , MD, FAHA, FRCPC , MD , and MD, FRCPC MD, FAHAOn behalf of the American Heart Association Council

Full Text available with Trip Pro

2017 American Heart Association

5. Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association

Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association November 14, 2017 Circulation. 2017;136:e348–e392. DOI: 10.1161/CIR.0000000000000535 e348 ABSTRACT: Life expectancy and quality of life for those born with congenital heart disease (CHD) have greatly improved over the past 3 decades. While representing a great advance for these patients, who have been able to move from childhood to successful (...) factors can be targeted for preventive intervention. A s survival to adulthood in individuals with congenital heart disease (CHD) has improved, adults with CHD are increasingly at risk for noncardiac com- plications. 1,2 The median age of adults with CHD has increased to 40 years, and the number of adults with CHD >65 years of age is steadily growing. 3–5 As pa- tients age, common adult comorbidities such as diabetes mellitus (DM), coronary artery disease, and hypertension may have an impact on long

Full Text available with Trip Pro

2017 American Heart Association

6. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. (PubMed)

Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Low cardiac output syndrome remains a serious complication, and accounts for substantial morbidity and mortality in the postoperative course of paediatric patients undergoing surgery for congenital heart disease. Standard prophylactic and therapeutic strategies for low cardiac output syndrome are based mainly on catecholamines, which (...) data about adverse effects of levosimendan were limited. A meta-analysis of hypotension, one of the most feared side effects of levosimendan, was not feasible because of the heterogeneous expression of blood pressure values.The current level of evidence is insufficient to judge whether prophylactic levosimendan prevents low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. So far, no significant differences have been detected between

Full Text available with Trip Pro

2017 Cochrane

7. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. (PubMed)

Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Low cardiac output syndrome remains a serious complication, and accounts for substantial morbidity and mortality in the postoperative course of paediatric patients undergoing surgery for congenital heart disease. Standard prophylactic and therapeutic strategies for low cardiac output syndrome are based mainly on catecholamines, which (...) ; participants = 60; studies = 2). Published data about adverse effects of levosimendan were limited. A meta-analysis of hypotension, one of the most feared side effects of levosimendan, was not feasible because of the heterogeneous expression of blood pressure values.The current level of evidence is insufficient to judge whether prophylactic levosimendan prevents low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. So far, no significant

2017 Cochrane

8. Recurrent Congenital Heart Diseases Among Neonates Born to Mothers with Congenital Heart Diseases. (PubMed)

Recurrent Congenital Heart Diseases Among Neonates Born to Mothers with Congenital Heart Diseases. The frequency of newborns with congenital heart disease (CHD) is approximately 1% in the general population; however, the recurrence rate of CHD in mothers with CHD differs in ethnicity and reports. We therefore aimed to determine the prevalence of CHD among neonates born to mothers with CHD in our institute in Japan. We reviewed the medical charts of 803 neonates delivered by 529 women with CHD (...) . The rate of CHD in offsprings whose mothers have CHD was 3 times greater than that of mothers with healthy hearts. Almost half of neonates with CHD had the same phenotype as their mother in our series. Especially, PS and CoA were closely related to the type of maternal CHD.

2019 Pediatric Cardiology

9. The dental management of children with congenital heart disease following the publication of Paediatric Congenital Heart Disease Standards and Specifications. (PubMed)

The dental management of children with congenital heart disease following the publication of Paediatric Congenital Heart Disease Standards and Specifications. The Paediatric Congenital Heart Disease Standards and Specifications (PCHDSS) were published in May 2016 by NHS England. The standards describe in detail the cardiac care patients should expect in England. They are also the first cardiology standards to include an oral health section. The dental standards outline what oral health care (...) patients should receive from both cardiology and dental healthcare professionals, with immediate effect. Children with congenital heart disease (CHD) are at increased risk of infective endocarditis and often have poorer oral health compared to healthy children. Children with cardiac disease can be complex to manage appropriately due to their increased dental anxiety and reduced access to dental care. The PCHDSS dental section highlights the importance of collaborative working between cardiology

2019 British Dental Journal

10. Pulse oximetry screening in newborns to enhance detection of critical congenital heart disease

Pulse oximetry screening in newborns to enhance detection of critical congenital heart disease Pulse oximetry screening is safe, noninvasive, easy to perform and proven to enhance detection of critical congenital heart disease in newborns. However, this test has yet to be adopted as routine practice in Canada. The present practice point highlights essential details and recommendations for screening, which research has shown to be highly specific, with low false-positive rates. Optimal screening (...) for critical congenital heart disease should include prenatal ultrasound, physical examination and pulse oximetry screening. Screening should be performed between 24 hours and 36 hours postbirth, using the infant’s right hand and either foot to minimize false-positive results. Newborns with abnormal results should undergo a thorough evaluation by the most responsible health care provider. When a cardiac diagnosis cannot be excluded, referral to a paediatric cardiologist for consultation

2017 Canadian Paediatric Society

11. Effect of race on the timing of the Glenn and Fontan procedures for single-ventricle congenital heart disease

Effect of race on the timing of the Glenn and Fontan procedures for single-ventricle congenital heart disease PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2017 PedsCCM Evidence-Based Journal Club

12. Pulse oximetry screening in newborns to enhance detection of critical congenital heart disease

Pulse oximetry screening in newborns to enhance detection of critical congenital heart disease Pulse oximetry screening is safe, noninvasive, easy to perform and proven to enhance detection of critical congenital heart disease in newborns. However, this test has yet to be adopted as routine practice in Canada. The present practice point highlights essential details and recommendations for screening, which research has shown to be highly specific, with low false-positive rates. Optimal screening (...) for critical congenital heart disease should include prenatal ultrasound, physical examination and pulse oximetry screening. Screening should be performed between 24 hours and 36 hours postbirth, using the infant’s right hand and either foot to minimize false-positive results. Newborns with abnormal results should undergo a thorough evaluation by the most responsible health care provider. When a cardiac diagnosis cannot be excluded, referral to a paediatric cardiologist for consultation

2017 Canadian Paediatric Society

13. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines 30586767 2019 04 01 1524-4539 139 14 2019 Apr 02 Circulation Circulation 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. e698-e800 10.1161/CIR (...) .0000000000000603 Stout Karen K KK Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for recusal information. †ACC/AHA Representative. ‡International Society for Adult Congenital Heart Disease Representative. §Society for Cardiovascular Angiography and Interventions Representative. ‖ACC/AHA Task Force on Clinical Practice Guidelines Liaison. ¶Society of Thoracic Surgeons Representative. #American

Full Text available with Trip Pro

2019 EvidenceUpdates

14. Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on

Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Patients with systemic morphological right ventricles (RVs), including congenitally corrected transposition of the great arteries and dextro-transposition of the great arteries with a Mustard or Senning atrial baffle repair, have a high (...) with systemic RV dysfunction. Randomized controlled trials or comparative-effectiveness studies that are sufficiently powered to demonstrate effect are needed to elucidate the efficacy of ACE inhibitors, ARBs, beta blockers, and aldosterone antagonists in patients with systemic RVs.Copyright © 2019 American Heart Association, Inc., and the American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

2019 EvidenceUpdates

15. Adults With Congenital Heart Disease

Adults With Congenital Heart Disease Accepted Manuscript 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease Karen K. Stout, MD, FACC, Chair, Writing Committee, Curt J. Daniels, MD, Vice Chair, Writing Committee, Jamil A. Aboulhosn, MD, FACC, FSCAI, Writing Committee Member, Biykem Bozkurt, MD, PhD, FACC, FAHA, Writing Committee Member, Craig S. Broberg, MD, FACC, Writing Committee Member, Jack M. Colman, MD, FACC, Writing Committee Member, Stephen R. Crumb, DNP (...) DOI: 10.1016/j.jacc.2018.08.1029 Reference: JAC 25255 To appear in: Journal of the American College of Cardiology Please cite this article as: Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF, 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease, Journal of the American College of Cardiology (2018), doi: 10.1016/j.jacc.2018.08.1029. This is a PDF

2018 American College of Cardiology

16. Radiation Safety in Children with Congenital and Acquired Heart Disease: A Scientific Position Statement on Multimodality Dose Optimization from the Image Gently Alliance

Radiation Safety in Children with Congenital and Acquired Heart Disease: A Scientific Position Statement on Multimodality Dose Optimization from the Image Gently Alliance Radiation Safety in Children with Congenital and Acquired Heart Disease: A Scientific Position Statement on Multimodality Dose Optimization from the Image Gently Alliance | JACC: Cardiovascular Imaging Advertisement User menu Source Search for this keyword Search Source Search for this keyword Search JACC: Cardiovascular (...) Imaging DOI: 10.1016/j.jcmg.2017.04.003 Just Accepted Radiation Safety in Children with Congenital and Acquired Heart Disease: A Scientific Position Statement on Multimodality Dose Optimization from the Image Gently Alliance Kevin D. Hill , Donald P. Frush , B. Kelly Han , Brian G. Abbott , Aimee K. Armstrong , Robert A. DeKemp , Andrew C. Glatz , S. Bruce Greenberg , Alexander Sheldon Herbert , Henri Justino , Douglas Mah , Mahadevappa Mahesh , Cynthia K. Rigsby , Timothy C. Slesnick , Keith J

Full Text available with Trip Pro

2017 Society for Cardiovascular Angiography and Interventions

17. Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank. (PubMed)

Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank. Despite the well-defined association of high-sensitivity hsCRP with cardiovascular outcomes in apparently healthy adults and those with acquired heart disease, the relevance of this inflammatory marker in adults with congenital heart disease (ACHD) remains unclear. We aimed to examine the clinical correlates (...) -2.97; P = 0.0006] and all-cause mortality (11.9% vs. 1.5%, adjusted HR = 4.23, 95% CI 1.87-9.59; P = 0.0006). Elevated hsCRP was associated with adverse outcomes across ACHD subgroups and other patient characteristics.Adults with congenital heart disease with elevated hsCRP have not only worse functional status and exercise capacity, but also greater risk for death or non-elective cardiovascular hospitalization. Further study is warranted to characterize the role of inflammation

2018 European Heart Journal

18. Heart or heart-lung transplantation for patients with congenital heart disease in England. (PubMed)

Heart or heart-lung transplantation for patients with congenital heart disease in England. Increased longevity in patients with congenital heart disease (CHD) is associated with late complications, mainly heart failure, which may not be amenable to redo surgery and become refractory to medical therapy and so, trigger referral for transplantation. We assessed the current role and future prospects of heart and heart-lung transplantation for patients with CHD in England.We performed (...) a retrospective analysis of hospital episodes for England for 1997-2015, identifying patients with a CHD code (ICD-10 'Q2xx.x'), who underwent heart or heart-lung transplantation.In total, 469 transplants (82.2% heart and 17.8% heart-lung) were performed in 444 patients. Half of patients transplanted had mild or moderate CHD complexity, this percentage increased with time (p=0.001). While overall, more transplantations were performed over the years, the proportion of heart-lung transplants declined (p<0.0001

2019 Heart

19. CCS/CPCA Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease

CCS/CPCA Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 33, Issue 2, Pages 199–208 Canadian (...) Cardiovascular Society/Canadian Pediatric Cardiology Association Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease x Kenny K. Wong Affiliations Pediatric Cardiology, IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada Correspondence Corresponding author: Dr Kenny K. Wong, IWK Health Centre, 5850 University Ave, Halifax, Nova Scotia B3K6R8, Canada. Tel.: +1-902-470-6956; fax: +1-902-470-6616. , MD (Co-Chair) a , ∗ , x Kenny K

2016 Canadian Cardiovascular Society

20. Congenital heart disease and pregnancy: A contemporary approach to counselling, pre-pregnancy investigations and the impact of pregnancy on heart function (PubMed)

Congenital heart disease and pregnancy: A contemporary approach to counselling, pre-pregnancy investigations and the impact of pregnancy on heart function Cardiac disease in pregnancy is a challenging clinical problem. The number of women pursuing pregnancy and the underlying complexity of their cardiac disease is increasing, such that heart disease is now the leading cause of maternal mortality in developed countries. Women with congenital heart disease make up the majority of these cases (...) and although maternal mortality is infrequent, a good outcome is only achieved though meticulous multidisciplinary care, beginning with pre-pregnancy counselling. All women with congenital heart disease should be assessed and be referred for pre-conception counselling prior to pregnancy and should receive thorough clinical assessment prior to pregnancy. In some conditions, such as pulmonary hypertension or severe/progressive aortic dilatation, pregnancy is of very high risk and women should be made aware

Full Text available with Trip Pro

2017 Obstetric medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>